Multiple sclerosis drugs on Blue Cross MedicareRx Basic (S5715-012)
Kesimpta, teriflunomide, dimethyl fumarate and the other MS drugs Part D covers, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Illinois
- Premium
- $89.70/month
- Deductible
- $615.00
2 of 8 Multiple sclerosis drugs are covered on this plan. All 2 require prior authorization.
6 aren't on the formulary, including teriflunomide and Vumerity.
- $12,016.93Tier 5
- from $44.01Tier 4
Not on the formulary
teriflunomide, Vumerity, fingolimod, Mayzent, Zeposia, Mavenclad
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.